Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06494163 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Exercise Training in Women With Heart Disease 2

Study acronym: EXCEED2
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Eligibility criteria expanded, about 9 words
    • Secondary endpoints: details revised at 8 of 13 entries
  2. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Aug 12, 2024 to Jan 27, 2025
    • Site details revised
    v3
  3. Study description expanded, about 3 wordsv2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study will compare the effects of two different types of training on exercise capacity in women with coronary heart disease (CHD). Participants will be randomized into either the virtual high-intensity interval training (HIIT) or the virtual moderate-to-vigorous intensity continuous training (MICT). After randomization, patients will exercise twice a week, for 12 weeks. The sessions will be conducted virtually. Patients will undergo a maximal exercise test, cardiometabolic indicators (height (cm), body mass (kg), body composition (%), waist circumference (cm) and, resting blood pressure) and complete questionnaires about quality of life, mental health, self-determined motivation, self-efficacy and enjoyment.
Trial Details
NCT Number NCT06494163
Lead Sponsor Ottawa Heart Institute Research Corporation
Conditions
(from sponsor)		 Cardiovascular Diseases, Coronary Heart Disease
Related terms Cardiovascular Diseases, Coronary Disease
Enrollment 172 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov